Study of KITE-197 in Participants With Relapsed or Refractory Large B-cell Lymphoma
Condition(s):Relapsed/Refractory Large B-cell LymphomaLast Updated:March 13, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Relapsed/Refractory Large B-cell LymphomaLast Updated:March 13, 2024Recruiting
Condition(s):Gastric Cancer; Gastroesophageal Junction AdenocarcinomaLast Updated:February 8, 2024Active, not recruiting
Condition(s):CRCLast Updated:May 31, 2023Recruiting
Condition(s):Patients With Advanced Malignant TumorsLast Updated:April 11, 2022Unknown status
Condition(s):Pregnancy Complications; Cesarean Section Complications; Morbidity;PerinatalLast Updated:May 6, 2023Completed
Condition(s):Non-small Cell Lung CancerLast Updated:November 17, 2022Recruiting
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:July 26, 2022Recruiting
Condition(s):Breast CancerLast Updated:December 2, 2019Unknown status
Condition(s):Plasma Cell Leukemia; Plasmacytoma; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell MyelomaLast Updated:December 13, 2023Active, not recruiting
Condition(s):Contiguous Stage II Small Lymphocytic Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Prolymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage I Small Lymphocytic Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage III Small Lymphocytic Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Small Lymphocytic LymphomaLast Updated:April 3, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.